Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02030457 · ClinicalTrials.gov registry record · Phase 1
A Study to Investigate the Pharmacokinetics and Safety of Beclomethasone Dipropionate Administered by Breath-Actuated Inhaler and Metered-Dose Inhaler in Healthy Adults
A Phase 1 study, sponsored by Teva Branded Pharmaceutical Products R&D.
- Completed
- Registry status
- Phase 1
- Development phase
- 72
- Enrollment target
NCT02030457 is a Phase 1 study that has completed, run by Teva Branded Pharmaceutical Products R&D. The registered enrollment target is 72 participants.
The verdict
NCT02030457, a Phase 1 study, has completed, sponsored by Teva Branded Pharmaceutical Products R&D.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 72 participants
- Enrollment target
Study Summary
This study is designed to compare the systemic exposure of orally inhaled beclomethasone dipropionate inhalation aerosol delivered via BAI to that delivered via MDI.
Interventions
- DRUG Beclomethasone dipropionate BAI
- DRUG Beclomethasone dipropionate MDI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2013-12 |
| Est. Completion | 2014-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02030457
The ClinicalTrials.gov registry entry for NCT02030457 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Teva Branded Pharmaceutical Products R&D, which has 167 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Beclomethasone dipropionate BAI is the first listed.
NCT02030457 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02030457 about?
NCT02030457 is a clinical study titled "A Study to Investigate the Pharmacokinetics and Safety of Beclomethasone Dipropionate Administered by Breath-Actuated Inhaler and Metered-Dose Inhaler in Healthy Adults". This study is designed to compare the systemic exposure of orally inhaled beclomethasone dipropionate inhalation aerosol delivered via BAI to that delivered via MDI.
What is the current status of trial NCT02030457?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 72 participants. The study started on 2013-12. Estimated completion is 2014-06.
What interventions are being tested in trial NCT02030457?
The interventions under investigation include: Beclomethasone dipropionate BAI (DRUG), Beclomethasone dipropionate MDI (DRUG).
Who is sponsoring clinical trial NCT02030457?
This trial is sponsored by Teva Branded Pharmaceutical Products R&D, which has 167 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.